ATE518874T1 - Synthetische lipid-a analogen und verwendungen davon - Google Patents

Synthetische lipid-a analogen und verwendungen davon

Info

Publication number: ATE518874T1
Authority: AT; Austria
Prior art keywords: lipid; synthetic; structures; novel; disaccharide
Prior art date: 1999-11-15

Application number

AT00980380T

Other languages

English (en)

Inventor

Zi-Hua Jiang

Mimi Bach

Damayanthi Yalamati

Rao Koganty

Michael Longenecker

Original Assignee

Oncothyreon Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-11-15

Filing date

2000-11-15

Publication date

2011-08-15

2000-11-15 Application filed by Oncothyreon Inc filed Critical Oncothyreon Inc

2011-08-15 Application granted granted Critical

2011-08-15 Publication of ATE518874T1 publication Critical patent/ATE518874T1/de

Links

GZQKNULLWNGMCW-PWQABINMSA-N lipid A (E. coli) Chemical class O1[C@H](CO)[C@@H](OP(O)(O)=O)[C@H](OC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)[C@@H](NC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCC)[C@@H]1OC[C@@H]1[C@@H](O)[C@H](OC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](NC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](OP(O)(O)=O)O1 GZQKNULLWNGMCW-PWQABINMSA-N 0.000 abstract 5
150000002016 disaccharides Chemical class 0.000 abstract 2
150000002632 lipids Chemical group 0.000 abstract 2
101001133056 Homo sapiens Mucin-1 Proteins 0.000 abstract 1
108010028921 Lipopeptides Proteins 0.000 abstract 1
206010028980 Neoplasm Diseases 0.000 abstract 1
230000000052 comparative effect Effects 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
230000003308 immunostimulating effect Effects 0.000 abstract 1
239000002502 liposome Substances 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
150000002772 monosaccharides Chemical class 0.000 abstract 1
238000006467 substitution reaction Methods 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1
230000001988 toxicity Effects 0.000 abstract 1
231100000419 toxicity Toxicity 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
- C07H13/06—Fatty acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/812—Liposome comprising an antibody, antibody fragment, antigen, or other specific or nonspecific immunoeffector

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Preparation (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Peptides Or Proteins (AREA)

AT00980380T 1999-11-15 2000-11-15 Synthetische lipid-a analogen und verwendungen davon ATE518874T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US16492899P	1999-11-15	1999-11-15
PCT/US2000/031281 WO2001036433A2 (en)	1999-11-15	2000-11-15	Synthetic lipid-a analogs and uses thereof

Publications (1)

Publication Number	Publication Date
ATE518874T1 true ATE518874T1 (de)	2011-08-15

Family

ID=22596692

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT00980380T ATE518874T1 (de)	1999-11-15	2000-11-15	Synthetische lipid-a analogen und verwendungen davon

Country Status (8)

Country	Link
US (1)	US7491707B1 (de)
EP (1)	EP1232168B1 (de)
JP (1)	JP2003514824A (de)
AT (1)	ATE518874T1 (de)
AU (1)	AU780577B2 (de)
CA (1)	CA2396744C (de)
ES (1)	ES2370262T3 (de)
WO (1)	WO2001036433A2 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2004533421A (ja)	2001-03-27	2004-11-04	バイオミラ，インコーポレイテッド	Ｔ１免疫応答とｔ２免疫応答との間で調節するためのワクチン
CA2482477A1 (en) *	2002-04-15	2003-10-30	Biomira, Inc.	Synthetic glyco-lipo-peptides as vaccines
ATE457733T1 (de)	2002-05-09	2010-03-15	Oncothyreon Inc	Lipid-a- und andere kohlenhydrat-liganden-analoga
AU2003242470A1 (en) *	2002-06-18	2003-12-31	Sankyo Company, Limited	1-carboxymethyl analogues of glucosyl lipid a
AU2002950657A0 (en) *	2002-08-08	2002-09-12	Alchemia Limited	Derivatives of monosaccharides for drug discovery
AU2002951995A0 (en)	2002-10-11	2002-10-31	Alchemia Limited	Classes of compounds that interact with gpcrs
US7960522B2 (en) *	2003-01-06	2011-06-14	Corixa Corporation	Certain aminoalkyl glucosaminide phosphate compounds and their use
HUE026376T2 (en) *	2003-01-06	2016-05-30	Corixa Corp	Certain aminoalkyl glucosamide phosphate compounds and their use
EP1547581A1 (de) *	2003-12-23	2005-06-29	Vectron Therapeutics AG	Liposomaler Impstoff für die Behandlung von menschlichen hematologischen mlignen Erkrankungen
TWI395591B (zh)	2004-04-01	2013-05-11	Oncothyreon Inc	黏液性糖蛋白（ｍｕｃ-１）疫苗
PT1896051E (pt)	2005-06-28	2015-01-13	Oncothyreon Inc	Método de tratamento de pacientes com uma vacina de glicoproteína mucinosa (muc-1)
EP1803814A1 (de) *	2005-12-27	2007-07-04	SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A.	Methode zur Verbesserung der Antikörperselektionskapazität in einer Phagen-Display-Bibliothek
PL2484375T3 (pl)	2006-09-26	2018-09-28	Infectious Disease Research Institute	Kompozycja szczepionki zawierająca syntetyczny adiuwant
US20090181078A1 (en) *	2006-09-26	2009-07-16	Infectious Disease Research Institute	Vaccine composition containing synthetic adjuvant
WO2008059307A2 (en) *	2006-11-16	2008-05-22	Om Pharma	Functionalized beta 1,6 glucosamine disaccharides and process for their preparation
WO2010078045A2 (en) *	2008-12-17	2010-07-08	Oncothyreon, Inc.	Method of making small liposomes
AU2010256461B2 (en)	2009-06-05	2016-03-17	Access To Advanced Health Institute	Synthetic glucopyranosyl lipid adjuvants
US20130236486A1 (en) *	2010-06-11	2013-09-12	Mayo Foundation For Medical Education And Research	Immunogenic vaccine
CA2825972A1 (en)	2011-02-24	2012-08-30	Oncothyreon Inc.	Muc1 based glycolipopeptide vaccine with adjuvant
JP6054942B2 (ja)	2011-04-08	2016-12-27	イミューンデザインコーポレイション	免疫原性組成物、ならびに体液性および細胞性免疫応答を誘発するための該組成物の使用方法
CA2890084C (en)	2011-11-18	2021-05-04	Maura Ellen Campbell	Synthetic derivatives of mpl and uses thereof
US9518078B2 (en)	2012-04-12	2016-12-13	Avanti Polar Lipids, Inc.	Disaccharide synthetic lipid compounds and uses thereof
US9241988B2 (en) *	2012-04-12	2016-01-26	Avanti Polar Lipids, Inc.	Disaccharide synthetic lipid compounds and uses thereof
SMT201800368T1 (it)	2012-05-16	2018-09-13	Immune Design Corp	Vaccini per l'infezione da virus-2 herpes simplex
WO2014172637A1 (en)	2013-04-18	2014-10-23	Immune Design Corp.	Gla monotherapy for use in cancer treatment
US9463198B2 (en)	2013-06-04	2016-10-11	Infectious Disease Research Institute	Compositions and methods for reducing or preventing metastasis
JP2018509384A (ja)	2015-01-06	2018-04-05	イミューノヴァクシーンテクノロジーズインコーポレイテッドＩｍｍｕｎｏｖａｃｃｉｎｅＴｅｃｈｎｏｌｏｇｉｅｓＩｎｃ．	リピドａ模倣体、調製方法、及びその使用
CN109125250B (zh) *	2018-08-30	2022-07-19	陕西中医药大学	一种小分子凝胶剂及制备方法和妇科用固-液互变型凝胶制剂
WO2020082162A1 (en) *	2018-10-26	2020-04-30	Alberta Research Chemicals Inc.	Synthetic innate immune receptor ligands and uses thereof
US20220339283A1 (en) *	2019-09-10	2022-10-27	The Penn State Research Foundation	Lipopolysaccharide molecules for enhancing immune responses
CN113214329A (zh) *	2020-01-21	2021-08-06	上海医药工业研究院	Lipid X及其中间体的制备方法、其中间体
KR20230026438A (ko)	2020-06-22	2023-02-24	스미토모 파마 가부시키가이샤	Tlr4 작동 활성을 갖는 아쥬반트

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4235871A (en)	1978-02-24	1980-11-25	Papahadjopoulos Demetrios P	Method of encapsulating biologically active materials in lipid vesicles
US4501728A (en)	1983-01-06	1985-02-26	Technology Unlimited, Inc.	Masking of liposomes from RES recognition
US5019369A (en)	1984-10-22	1991-05-28	Vestar, Inc.	Method of targeting tumors in humans
US5554372A (en) *	1986-09-22	1996-09-10	Emory University	Methods and vaccines comprising surface-active copolymers
US4837028A (en)	1986-12-24	1989-06-06	Liposome Technology, Inc.	Liposomes with enhanced circulation time
ZA881430B (de)	1988-03-02	1988-10-28
US5134230A (en) *	1988-03-02	1992-07-28	Daiichi Pharmaceutical Co., Ltd.	2-Deoxy-2-aminoglucopyranoside derivatives
US4912094B1 (en)	1988-06-29	1994-02-15	Ribi Immunochem Research Inc.	Modified lipopolysaccharides and process of preparation
IE920710A1 (en) *	1991-03-06	1992-09-09	Searle & Co	Phenyl amidines derivatives useful as platelet aggregation¹inhibitors
AU660325B2 (en)	1991-10-11	1995-06-22	Eisai Co. Ltd.	Anti-endotoxin compounds and related molecules and methods
WO1995014026A1 (en) *	1993-11-17	1995-05-26	Laboratoires Om S.A.	Glucosamine disaccharides, method for their preparation, pharmaceutical composition comprising same, and their use
US5648343A (en) *	1994-02-28	1997-07-15	The University Of Georgia Research Foundation	Method for treating LPS-mediated disorders
CA2189356A1 (en)	1994-05-02	1995-11-09	Ting Chi Wong	Process for preparation of glycosides of tumor-associated carbohydrate antigens
US6887483B2 (en) *	1995-12-01	2005-05-03	University Of Iowa Research Foundation	Non-toxic mutants of pathogenic gram-negative bacteria
WO1998033810A2 (en)	1997-01-30	1998-08-06	University Of Virginia Patent Foundation	Cysteine-depleted peptides recognized by a3-restricted cytotoxic lymphocytes, and uses therefor

2000
- 2000-11-15 EP EP00980380A patent/EP1232168B1/de not_active Expired - Lifetime
- 2000-11-15 AT AT00980380T patent/ATE518874T1/de not_active IP Right Cessation
- 2000-11-15 WO PCT/US2000/031281 patent/WO2001036433A2/en active IP Right Grant
- 2000-11-15 CA CA2396744A patent/CA2396744C/en not_active Expired - Fee Related
- 2000-11-15 ES ES00980380T patent/ES2370262T3/es not_active Expired - Lifetime
- 2000-11-15 JP JP2001538922A patent/JP2003514824A/ja active Pending
- 2000-11-15 US US10/130,055 patent/US7491707B1/en not_active Expired - Fee Related
- 2000-11-15 AU AU17647/01A patent/AU780577B2/en not_active Ceased

Also Published As

Publication number	Publication date
ES2370262T3 (es)	2011-12-14
EP1232168A2 (de)	2002-08-21
AU1764701A (en)	2001-05-30
JP2003514824A (ja)	2003-04-22
AU780577B2 (en)	2005-04-07
CA2396744C (en)	2011-07-12
EP1232168B1 (de)	2011-08-03
WO2001036433A2 (en)	2001-05-25
US7491707B1 (en)	2009-02-17
WO2001036433A3 (en)	2002-05-10
CA2396744A1 (en)	2001-05-25

Publication	Publication Date	Title
ATE518874T1 (de)	2011-08-15	Synthetische lipid-a analogen und verwendungen davon
ATE232109T1 (de)	2003-02-15	Synthetische, vielfache tandemwiederholungen des mucinpeptides und seiner derivate und deren verwendung
AU591309B2 (en)	1989-11-30	Taxol derivatives, their preparation and pharmaceutical compositions containing them
YU182691A (sh)	1994-01-20	Postupak za dobijanje derivata taksana i dobijeni novi derivati
DE69531204D1 (de)	2003-08-07	Formulierungen fuer faktor ix
ES2173480T3 (es)	2002-10-16	Preparacion de derivados de ciclohexeno carboxilato.
RU94042922A (ru)	1996-12-27	Новые соединения, способы их получения, фармацевтическая композиция
BR9917230A (pt)	2002-01-08	Mistura de diésteres de nonanol isomérico de um ácido dicarboxìlico, e, uso da mesma
ES2074734T5 (es)	2002-02-16	Utilizacion de composiciones a base de alcoholes grasos, para la preparacion de emulsiones; procedimiento de preparacion de emulsiones y emulsiones asi obtenidas.
WO1996039193A3 (en)	1997-06-05	Drug mitochondrial targeting agents
CA2278201A1 (en)	1998-07-23	Novel modifications to 2-amino-4-(4-fluorobenzylamino)-1-ethoxycarbonyl-aminobenzene, and processes for their preparation
HUP0002454A2 (hu)	2000-12-28	D-Vitamin-molekularésszel rendelkező konjugátumok és ilyen konjugátumokat tartalmazó gyógyászati készítmények
CA2263136A1 (en)	1998-02-26	Preparation of cyclohexene carboxylate derivatives
DK0789590T3 (da)	2002-11-04	Chitosaninduceret immunforstærkning
AU1436097A (en)	1997-05-07	Sulphamate derivatives of 1,3,5(10)-estratriene derivatives, methods of producing them and pharmaceutical compounds containing them
MY120683A (en)	2005-11-30	New phenylamidine derivatives, processes for their preparation and their use as pharmaceuticals.
KR920702853A (ko)	1992-10-28	신규 글루코사민 유도체 및 이것을 막 구성성분으로서 함유한 리포솜
CA2155018A1 (en)	1994-08-04	C7 taxane derivatives and pharmaceutical compositions containing them
ATE546457T1 (de)	2012-03-15	Verfahren und zusammensetzungen zur herstellung von c-3' und c-4' -anthracyclin antibiotika
IL141325A0 (en)	2002-03-10	Tan-1057 derivatives
CA2263846A1 (en)	1998-03-19	Novel pyranoside derivatives
CA2077606A1 (en)	1993-04-10	Inhibited 141b
GB2023145A (en)	1979-12-28	Hydrocortisone derivatives, their preparation and pharmaceutical compositions containing them
TW369531B (en)	1999-09-11	New taxoids, their preparation and pharmaceutical compositions containing them
EP1444247A4 (de)	2004-12-08	Neue tibolonformulierungen

Legal Events

Date	Code	Title	Description
2012-02-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties